Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Abbott Labs

Johnson Controls

Pentair

Zoetis

Zoetis, Pentair, Johnson Controls International, and Abbott Laboratories were among the many companies that declared dividend increases this week.

CVS, Abbot, and Other Companies That Raised Their Dividends This Week

Zoetis, CVS Health, and Other Companies That Raised Their Dividends

The stock price of CVS Health Corp (NYSE: CVS) increased by over 1.5% today. This is why it happened.

CVS Health Stock (CVS): Why The Price Increased Today

Walgreens

Target

The CEOs from 20 major retail brands, including Target TGT, +0.04% , CVS CVS, +0.95% and Walgreens WBA, +0.33% , have jointly penned a letter to Congress over concerns of increasing crime in their stores.

The Margin: CEOs from Target, CVS and Walgreens ask Congress for help amid retail crime surge

Stryker

The healthcare sector is often one of the most recession-resistant areas of the market given that its products and services remain in demand even as the economy enters a downturn. People value their health as this impacts their quality of life, allowing companies in the healthcare sector to see rather consistent results throughout the economic cycle.

2 Healthcare Stocks Delivering Double-Digit Dividend Increases

CVS Health Corp. CVS, +0.87% said Friday it was raising its quarterly dividend to 10%, to 55 cents a share from 50 cents a share. The new dividend will be payable Feb. 1 to shareholders of record on Jan. 21.

CVS Health raises dividend by 10%, to lift implied yield to above 2.2%

CVS cut its shareholder returns a couple of years ago in order to pay for its acquisition of Aetna.

CVS Health Drops The Dividend Bombshell

Best Buy

Home Depot

Nordstrom

The CEOs of Target, Best Buy, Nordstrom, Home Depot and CVS are among a group of 20 retail leaders who sent a letter Thursday to Congress expressing their concern over a recent wave of brazen store robberies in major US cities and urged lawmakers to take action.

CEOs of Target, Best Buy, CVS and other retail chains ask Congress for help amid crime surge

CVS stock has been rising since its leaders announced a stock buyback investment. The company clearly foresees a strong year ahead.

CVS Stock Alert: There's a $10 Billion Reason CVS Health Is Rallying Today

The health-care executive joined a growing number of executives who have expressed concern about the rise in organized crimes.

CVS CEO Karen Lynch says smash-and-grab robberies fueled by online marketplaces

Drugstore chain and health insurer CVS Health said Thursday (Dec. 9) during its Investor Day 2021 presentations that its sales should grow as it continues to expand its services — both in stores and in people's homes — in its quest to make health care more accessible and easier to afford. During her Investor Day […]

CVS Expanding Healthcare Services, Expects Sales Jolt

CVS Health Corp (NYSE:CVS) shares traded higher Thursday after the company raised its fiscal 2022 financial guidance ahead of its upcoming investor day event. One analyst said the new outlook is encouraging for CVS investors, and the company has plenty of momentum heading into 2022.

CVS Stock Trades Higher Following Guidance Hike: What Investors Need To Know

CVS Health Corp (NYSE: CVS) is trading higher Thursday after the company updated its guidance and increased its dividend. CVS Health said that advancement of health services and primary care capabilities will augment performance in foundational businesses while creating new opportunities in high-growth markets.

Why CVS Health Shares Are Rising Today

CVS Health said it will be acquiring more physician practices and clinics as it expands its diversified strategy to grow its primary care business.

CVS Health To Escalate Physician Acquisitions In Primary Care Strategy

AutoZone

Kroger

Rite Aid

The chief executives of major U.S. retailers including Target, Home Depot, Kroger, CVS Health, Autozone and Best Buy on Thursday urged Congress to take action to address some anonymous online sales, citing the growing impact of organized retail crime.

Major U.S. retailers urge action by Congress on online sellers

Drugstore operator CVS Health Corp on Thursday forecast full-year 2022 adjusted profit and updated its current-year earnings estimate.

CVS Health provides 2022 profit forecast, updates current-year estimate

Shares of CVS Health Corp. CVS, +0.18% rose 0.6% in premarket trading Thursday, after the drug store chain and health care services company announced at its Investor Day a $10 billion stock repurchase program, a 10% boost to its dividend and lifted its full-year earnings outlook. The annual dividend rate was raised to $2.20 a share from $2.00 a share, which increases the implied dividend yield at Wednesday's stock closing price to 2.36% from 2.15%, which compares with the implied yield for the S&P 500 SPX, +0.31% of 1.31%.

CVS sets $10 billion stock buyback program, boosts dividend for first time in 4 years

CVS Health expects its earnings and revenue to grow in the year ahead, as it focuses on making health care more affordable and easier for customers.

CVS says it expects earnings, revenue to grow in 2022 as it steps up health-care focus

WOONSOCKET, R.I., Dec. 9, 2021 /PRNewswire/ -- Today at its 2021 Investor Day, the CVS Health (NYSE: CVS) leadership team will present a strategy that capitalizes on the significant opportunity to make health care more convenient, personalized and affordable for consumers.

CVS Health Presents Strategy for Revolutionizing Consumer Health Experience While Driving Profitable Growth

The drugstore chain and health insurer is expected to lay out its plans to use health-care services as a growth engine beyond the Covid pandemic.

3 themes to watch as CVS has its first investor day since start of pandemic

CVS Health's (CVS) collaboration with Microsoft will accelerate digital transformation and empower employees to provide more customized and affordable care.

CVS Health (CVS) New Alliance to Boost Digital Transformation

The market is giving value-conscious investors an early Christmas gift.

Value Investors Will Love This Diversified Healthcare Stock

WOONSOCKET, R.I., Dec. 6, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) marks National Influenza Vaccination Week (December 5-11) by reminding everyone that it's not too late to get a flu shot.

CVS Health Reminds Americans to Get Their Flu Shot During National Influenza Vaccination Week

Microsoft

Microsoft (MSFT) will be teaming up with CVS Health to advance work on developing innovative solutions to boost customer health outcomes.

Microsoft (MSFT) to Support CVS Health's Digital Transformation

Costco

GameStop

Toll Brothers

AutoZone, Brown-Forman, Broadcom, and others will also report earnings. Economic data to be released this week include consumer credit for October and the consumer price index for November.

News for CVS Health Stock (CVS)